zoom_in Click to enlarge

Jonas Salk

▲ ▼

description Jonas Salk Overview

Jonas Salk was a pioneering American medical researcher whose development of an inactivated poliovirus vaccine in 1955 marked a critical advancement in preventative medicine. His work dramatically reduced polio incidence globally and remains foundational to immunology research. Primarily for public health officials, healthcare professionals, and those studying the history of scientific breakthroughs in combating infectious diseases.

help Jonas Salk FAQ

What is Jonas Salk famous for developing?

Dr. Jonas Salk is famous for developing the first safe and effective inactivated poliovirus vaccine (IPV). His groundbreaking work was announced to the public on April 12, 1955, effectively ending the terror of polio epidemics in the United States.

Did Jonas Salk patent his polio vaccine?

No, Jonas Salk famously chose not to patent his polio vaccine, foregoing any personal profit to ensure it could be distributed as widely as possible. When asked who owned the patent, he reportedly stated, 'Well, the people, I would say.'

How does the Salk vaccine differ from the Sabin vaccine?

Salk's vaccine relies on an inactivated (killed) virus and is administered via injection. Albert Sabin's later vaccine uses a live, attenuated (weakened) virus given orally, usually on a sugar cube.

When was the Salk polio vaccine first tested on a large scale?

The vaccine underwent one of the largest clinical trials in history in 1954, involving nearly two million schoolchildren across the United States. The success of this massive field trial paved the way for its nationwide approval.